Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Allergy Clin Immunol. 2015 Sep 11;137(1):204–213.e3. doi: 10.1016/j.jaci.2015.07.032

FIG 3.

FIG 3

SAM identifies reactivities associated with ACAAs against type I interferons and GM-CSF. Three-class SAM was applied based on cytokine reactivity to type I interferons, GM-CSF, or neither. SAM identified 14 statistically significant differences. These targets include cytokines purchased from multiple vendors. GMCSF reactivity and type I interferon–associated reactivity are boxed in green and purple, respectively, for emphasis.